A Phase 2/3 trial testing buntanetap in Alzheimer's patients is expected to be fully enrolled next month, with data expected in March 2024.| Alzheimer's News Today
Buntanetap, a small molecule from Annovis Bio, improved cognitive function in people with mild Alzheimer’s with certain biomarkers.| Alzheimer's News Today